期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

白细胞介素-32与疾病的关系研究进展 被引量：3

Advance in the research of relationship between IL-32 and diseases
下载PDF
导出
摘要 IL-32是新发现的一种促炎症细胞因子,它与多种疾病的发生发展有着密切关系。该文主要从IL-32的命名、产生、特性及其与多种疾病的关系进行介绍。 Interleukin-32 is a recently discovered proinflammatory cytokine that related with many diseases. This review has summarized the relationships between IL-32 and some diseases.
作者 田兆菊 王英 陈强 焦凤萍 马玉红
机构地区 泰山医学院公共卫生学院 莱芜市莱城区人民医院
出处 《免疫学杂志》 CAS CSCD 北大核心 2012年第11期994-997,共4页 Immunological Journal
基金 山东省优秀中青年科学家科研奖励基金(2008BS02005)
关键词 IL-32 特性 生物学功能 疾病 IL-32 Character Biological function Diseases
分类号 R392.12 [医药卫生—免疫学] R383.24 [医药卫生—医学寄生虫学]
  • 相关文献

参考文献27

  • 1Kim SH, Han SY, Azam T, et al. Interleukin-32: a cytokine and inducer of TNFalpha[J]. Immunity, 2005, 22(1): 131-142.
  • 2Dahl CA, Scha11 RP, He HL, et al. Identification of a novel gene expressed in activated natural killer cells and T cells[J]. J Immunol, 1992, 148(2): 597-603.
  • 3Panelli MC, Wang E, Phan G, et al. Gene-expression profiling of the response of peripheral blood mononuclear ceils and and melanoma metastases to systemic IL-2 administration[J]. Genome Biol, 2002, 3(7): RESEARCH 0035.
  • 4Choi JD, Bae SY, Hong JW, et al. Identification of the most active interleukin-32 isoform[J]. Immunology, 2009, 126(4): 535-542.
  • 5Netea MG, Azam T, Ferwerda G, et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism[J]. USA Proc Natl Acad Sci, 2005, 102(45): 16309-16314.
  • 6Goda C, Kanaji T, Kanaji S, et al. Involvement of IL-32 in activation-induced cell death in T cells [J]. Int Immunol, 2006, 18(2): 233-240.
  • 7Shoda H, Fujio K, Yamamoto K. Biomedicine & diseases: review rheumatoid arthritis and interleukin-32 [J]. Cell Mol Life Sci, 2007, 64(19/20):2671-2679.
  • 8Shoda H, Fujio K, Yamaguchi Y, et al. Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacer-bation of immune-inflammatory diseases[J]. Arthritis Res Ther, 2006, 8(6): 1-13.
  • 9Joosten LA, Netea MG, Kim SH, et al. IL-32, a proinflammatory cytokine in rheumatoid arthritis[J]. USA Proc Natl Acad Sci, 2006, 103(9): 3298-3303.
  • 10Atsushi Nishida, Akira Andoh, Osamu Inatomi, et al. Interleukin-32 expression in the pancreas[J]. J Bio Chem, 2009, 284(26): 17868-17876.

二级参考文献9

  • 1Netea MG, Azam T,Ferwerda G, et al.IL-32 synergizes with nucleotide oligomerization domain (NOD) land (NOD)2 ligands for IL-1β and IL-6 production through a caspase 1-dependent mechanism [J]. Proc Natl Acad Sci USA, 2005,102(45): 16309-16314.
  • 2Liu C J, Chen DS, Chen PJ. Epidemiology of HBV infection in Asian blood donors:emphasis on occult HBV infection and the role of NAT[J]. J Clin Virol2006, 36:S33-44.
  • 3Raimondo G, Pollicino T, Cacciola I, et al. Occult hepatitis B virus infection[J]. J Hepatol, 2007, 46:160-70.
  • 4Henning H, Puchta I, Luhm J, et al. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen[J]. Blood,2002,100:2637-41.
  • 5Allain JP. Occult hepatitis B virus infection: implications in transfusion[J]. Vox Sang,2004,86:83-91.
  • 6Kaminski G, Alnaqdy A, Al-Belushi I, Nograles J, Al-Dhahry SH. Evidence of occult hepatitis B virus infection among Omani blood donors: a preliminary study[J]. Med Princ Pract, 2006,15:368-72.
  • 7蔡卫平,唐小平,陈劲峰,张复春.慢性乙型肝炎HBV-DNA定量检测与病原学标志和肝损害程度的关系[J].中国实用内科杂志,1998,18(3):149-150. 被引量：77
  • 8中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量：14010
  • 9周卫敏,许青田.慢性乙型肝炎患者血清HBV DNA与病毒复制水平相关性分析[J].中国医药导报,2008,5(12):21-22. 被引量：2

共引文献2

同被引文献34

  • 1Kim SH, Han SY, Azam T, et al. Interh'ukin-32: a cytokine and nducer of TNFalpha[J]. lm,nunity, 2005, 22(1): 131-142.
  • 2Netea MG. Azam T, Ferwerda G, et al. IL-32 synergizes with nuch'otide oligomerizalion domain (NOD) 1 and NOD2 ligands for IL-Ibeta and IL-6 production through a caspase 1-dependent mechanism[J]. Proc Natl Acad Sci USA, 2005, 102(45): 16309-16314.
  • 3Chert Q, Carroll HP, Gadina M. The newest interleukins: recent additions to the ever-growing cytokine family [J]. Vitam Horm, 2006, 74: 207-228.
  • 4Goda C, Kanaji T, Kanaji S, et al. lnvolve,nent of IL-32 in activation-induced cell death in T cells[J]. Int Immunol, 2006, 18(2): 233-240.
  • 5Rasool ST, Tang H, Wu J, et al. Increased level of 11,-32 during human immunodeficiency virus infection suppresses H IV replication[J ]. lmmunol Lett, 2008, 117(2): 161-167.
  • 6Li W, Sun W, Liu L, et al. II,-32: a host proinflammatory factor against influenza viral replication is upregulated bv aberrant epigenetie modifirations during influenza A virus infection[J]. J Immunol, 2010, 185(9): 5056-5065.
  • 7Hcinhuis B, Koenders MI, van de Loo FA, et al. Inflammation-dependent secretion and splicing of IL-32 {gamma} in rheumatoid arthritis[J]. Prot. Natl Acad Sci USA. 2011, 108(12): 4962-4967.
  • 8Choi JD, Bae SY. Hong .IW, et al. ldentification of the most active interleukin-32 isofcrm[J]. Immunology, 2009, 126(4): 535-542.
  • 9Tagaya Y, Kurys G, Thies TA, et al. Generation of secretable and nonsecretable interleukin 15 isoforms through ahernate usage of signal peptides[J]. Proc Nail Acad Sci USA, 1997, 94(26): 14444-14449.
  • 10Kim SH, Han SY, Azam T, et al. Interleukin-32: a cytokine and inducer of TNFalpha[J]. Immunity, 2005, 22(1): 131-142.

引证文献3

二级引证文献6

免疫学杂志
2012年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部